MINIDIAB AF
GLIPIZIDE AND METFORMIN · by PFIZER
Composition
Tab 2.5/250 mg: Glipizide 2.5 mg, metformin 250 mg.Tab 2.5/500 mg: Glipizide 2.5 mg, metformin 500 mg. Tab 5/500 mg: Glipizide 5 mg, metformin 500 mg. Tab 5/250 mg: Glipizide 5 mg, metformin
Indications & Dosage
Type 2 Diabetes mellitus: Adults: Initially tab 2.5-5 mg Glipizideand metformin 250/500 mg daily, to be taken shortly before breakfast or lunch, adjusted according to response, dose higher than 15 mg to be given in divided doses; max. Glipizide20 mg and metformin HCI 2000 mgperday. Use appropriate strength as required. Children: Not recommended.
Contraindications
Porphyria, ketoacidosis, pre-coma and coma, severe renal or hepatic impairment, concomitant miconazole treatment, cardiac or respiratory failure, recent MI, alcoholism, administration of iodinated contrast materials. Discontinue for 48 hours before and after elective surgery.
Precautions
Assess risk factors for lactic acidosis; discontinue immediately if metabolic acidosis suspected, renal or hepatic impairment, obesity, adrenal or pituitary insufficiency, surgery, severe trauma, infections, G6PD deficiency, and elderly.
Pregnancy
Contraindicated in pregnancy.
Lactation
Contraindicated or not recommended.
Side Effects
Abnormal liver function tests, hepatitis, jaundice, blood dyscrasias, transient visual disturbances, skin reactions, reduced B12 absorptions, GI upset, taste disturbance, rarely lactic aci-dosis.